000 01461 a2200433 4500
005 20250515042403.0
264 0 _c20070509
008 200705s 0 0 eng d
022 _a1462-0324
024 7 _a10.1093/rheumatology/kel336
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPisoni, C N
245 0 0 _aMycophenolate mofetil treatment in resistant myositis.
_h[electronic resource]
260 _bRheumatology (Oxford, England)
_cMar 2007
300 _a516-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aBiomarkers
_xblood
650 0 4 _aCreatine Kinase
_xblood
650 0 4 _aDrug Administration Schedule
650 0 4 _aDrug Evaluation
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aGlucocorticoids
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aMiddle Aged
650 0 4 _aMuscle Strength
_xdrug effects
650 0 4 _aMycophenolic Acid
_xanalogs & derivatives
650 0 4 _aMyositis
_xdrug therapy
650 0 4 _aPrednisolone
_xadministration & dosage
650 0 4 _aRetrospective Studies
700 1 _aCuadrado, M J
700 1 _aKhamashta, M A
700 1 _aHughes, G R V
700 1 _aD'Cruz, D P
773 0 _tRheumatology (Oxford, England)
_gvol. 46
_gno. 3
_gp. 516-8
856 4 0 _uhttps://doi.org/10.1093/rheumatology/kel336
_zAvailable from publisher's website
999 _c16581316
_d16581316